Postpartum plasmapheresis treatment in a severe liver enzyme disorder

Koyuncu K., Kan Ö., Yüce T., TAŞKIN S., Söylemez F.

Turkiye Klinikleri Jinekoloji Obstetrik, cilt.28, sa.2, ss.75-77, 2018 (Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 28 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5336/gynobstet.2015-46783
  • Dergi Adı: Turkiye Klinikleri Jinekoloji Obstetrik
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database
  • Sayfa Sayıları: ss.75-77
  • Anahtar Kelimeler: HELLP syndrome, Plasmapheresis
  • Ankara Üniversitesi Adresli: Evet

Özet

Copyright © 2018 by Türkiye Klinikleri.HELLP syndrome is a severe form of preeclampsia that was first described by Weinstein in 1982. It is characterized by hemolysis, elevated liver enzymes, and low platelet count. HELLP develops in approximately 0.5-0.9% of all pregnancies and in 10-20% of pregnancies complicated with preeclampsia. HELLP syndrome is a severe complication that increases the risk of both fetal and maternal mortality. The treatment for HELLP syndrome is primarily based on the gestational age, and though the most effective treatment is delivery, other options are also available. Plasmapheresis is the preferred option for the complication of progressive liver function disorder. We present a case report of a 34-year-old pregnant woman suffering from HELLP syndrome, who showed dramatic improvement after plasmapheresis.